IHS Chemical Week

EnviroTech :: Biotech

Boehringer Ingelheim to Enter Biosimilars Business

1:17 AM MDT | September 27, 2011 | Deepti Ramesh

Boehringer Ingelheim (Ingelheim, Germany) says it will establish a new separate business for the development and commercialization of biosimilars. Biosimilars are approved versions of innovator biopharmaceutical products introduced after patent expiry. “We believe that biosimilars will become a major part of the biopharmaceutical market and will enable many more patients access to important medicines,” says Wolfram Carius, member of the board of managing directors and responsible for operations at Boehringer Ingelheim. The company will leverage its...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa